Romano Brothers & Co’s Sanofi SNY Stock Holding History

Romano Brothers & Co’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-497	Closed	-$24.1K	–	871
2022 Q4	$24.1K	Buy	+497	New	+$21.8K	﹤0.01%	588

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Romano Brothers & Co's SNY Position: Q1 2023 in Review

Romano Brothers & Co sold out of Sanofi (SNY) in Q1 2023, closing a stake of 497 shares — an estimated $24.1K sold.

Romano Brothers & Co first reported a position in SNY in Q4 2022 and held it in 1 quarter. The position peaked at $24.1K in Q4 2022. 678 funds tracked by Wall St. Rank hold SNY as of Q1 2023.

Romano Brothers & Co reported no remaining Sanofi position as of Q1 2023 after selling out during the quarter.
Romano Brothers & Co sold 497 Sanofi shares in Q1 2023, an estimated $24.1K.
Romano Brothers & Co first reported a position in Sanofi in Q4 2022 and held it in 1 quarter.
Romano Brothers & Co's Sanofi position peaked at $24.1K in Q4 2022.
678 funds tracked by Wall St. Rank held Sanofi as of Q1 2023.

Based on Romano Brothers & Co's 13F filing for Q1 2023, filed 13 Apr 2023.